Arcturus Therapeutics Holdings Inc. Common Stock

ARCTNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
9.91 USD
↗ 0.07 (0.71%)AT CLOSE (03:59 PM EDT)
9.93
↗ 0.02 (0.20%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
9.93
↗ 0.02 (0.20%)
🔴Market: CLOSED

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) trades at $9.92 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place ARCT at a fair price relative to peers.

Technical & fundamental data as of Oct 26, 2026.

Open?$9.72
High?$10.27
Low?$9.65
Prev. Close?$9.84
Volume?595.7K
Avg. Volume?739.8K
VWAP?$9.97
Rel. Volume?0.81x
Bid / Ask
Bid?$9.60 × 200
Ask?$10.50 × 300
Spread?$0.90
Midpoint?$10.05
Valuation & Ratios
Market Cap?281.7M
Shares Out?28.4M
Float?28.4M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?1.64
EPS?-$3.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsBiotech - Drug Development›Infectious Disease & Vaccines
Employees
111
Market Cap
279.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.arcturusrx.com
Listed
2013-05-22
Address
10285 SCIENCE CENTER DRIVE
SAN DIEGO, CA
Phone: (858) 900-2660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
1
Momentum?
10
Short Sent.?
45
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.83Distress
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.21%High
Short Interest?5.5M
Days to Cover?8.4
Free Float28.4M
Avg Daily Volume653.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?5.88Strong
Quick Ratio?5.88Strong
Cash Ratio?5.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
84
1.64CHEAP▾
P/S?
Peers
100
S&P
9
9.59HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.9CHEAP▾
EV/Sales?
Peers
100
S&P
60
3.07FAIR▾
Returns & Efficiency
ROE?
S&P
3
-54.3%WEAK▾
ROA?
S&P
3
-41.6%WEAK▾
Cash Flow & Enterprise
FCF?$-72822000
Enterprise Value?$90.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist